查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997450

動物腸道健康市場：2026-2032年全球市場預測（依產品類型、目標動物、劑型、應用及通路分類）

Animal Intestinal Health Market by Product Type, Animal Type, Formulation, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動物腸道健康市場價值將達到 45.2 億美元，到 2026 年將成長至 47.9 億美元，到 2032 年將達到 68.8 億美元，年複合成長率為 6.17%。

主要市場統計數據
基準年 2025 45.2億美元
預計年份：2026年 47.9億美元
預測年份 2032 68.8億美元
複合年成長率 (%) 6.17%

在微生物組科學的指導下，將腸道健康作為整個動物生產系統中商業性和永續性的核心驅動力進行策略性實施。

動物腸道健康領域已從一種小眾的營養補充品發展成為畜牧業、水產養殖業和伴侶動物生產系統的核心支柱。微生物組科學的進步重新定義了腸道健康，將其視為一種受飼料配方、靶向生物活性物質、宿主免疫力和管理措施等多因素影響的結果。因此，生產者和價值鏈上的相關人員越來越重視制定以最佳化腸道功能為核心的干涉策略，以提高動物的適應能力、資源利用效率和福祉。

科學突破、監管壓力和數位物流的整合如何加速動物腸道健康領域的一體化產品創新和應用。

過去五年，腸道健康領域經歷了翻天覆地的變化，產品系列、供應鏈和消費者期望都發生了重塑。科學的進步拓展了有效干預方案的範圍，從單一模式療法發展到整合酶、有機酸、植物萃取物、益生元和益生菌等多種成分，並結合性能診斷技術。菌株鑑定技術的進步、提高穩定性的包封技術以及針對不同物種和生命階段特定生理需求的顆粒製劑的開發，都在加速這一整合進程。

評估 2025 年關稅對動物腸道健康生態係原料採購、配方決策和供應鏈韌性的影響。

2025年新關稅措施的實施，凸顯了依賴跨國原料分銷和配方產品的相關人員面臨的貿易和成本複雜性。這些關稅正在影響進口酵素複合物、特殊有機酸和專有益生菌菌株的經濟效益，迫使製造商和經銷商重新評估其籌資策略和庫存政策。在實踐中，採購部門越來越重視供應商多元化、本地製造夥伴關係以及後向整合，以在控制成本的同時維持供應的連續性。

以細分市場為中心的洞察，揭示產品類型、動物物種生理、預期用途、配方限制和分銷策略如何決定開發路徑。

深入的市場區隔分析揭示了不同產品類型、動物種類、應用領域、配方和分銷管道的市場需求促進因素和產品開發重點。依產品類型分類，市場可細分為酵素、有機酸、植物來源成分、益生元和益生菌。酵素又可細分為植酸酶、蛋白酶和木聚醣酶，而益生菌則可細分為細菌益生菌和酵母益生菌。這種細分凸顯了配方科學的重要性，即需要使觸媒活性、pH耐受性和微生物相容性與目標飼料基質相匹配。依動物種類分類，市場可細分為水產養殖、伴侶動物、家禽、反芻動物和豬。水產養殖進一步細分為魚類和蝦類，伴侶動物細分為貓和狗，家禽細分為肉雞、蛋雞和火雞，反芻動物細分為牛、牛和山羊，豬細分為種豬、育肥豬和母豬及仔豬。這些分類突顯了不同物種和生命週期中腸道生理功能的差異，而這些差異決定了不同的給藥策略、載體系統和療效證據標準。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和戰略意義，這些趨勢和意義驅動著採購、監管策略和商業化。

區域差異是影響供應策略、監管合規性和農場實施的關鍵因素，美洲、歐洲、中東和非洲以及亞太地區的獨特趨勢塑造了商業性機會和風險。在美洲，大規模商業家禽和生豬養殖場優先考慮飼料轉換率和合理使用抗生素，這推動了市場需求，促使酵素製劑和益生菌干預措施與精準飼餵平台相結合得到快速應用。在歐洲、中東和非洲，法規結構和消費者期望強調減少抗生素使用和可追溯性，推動了對可嚴格檢驗且易於記錄的解決方案的需求，並促進了原料開發商和當地配料商之間的合作。

公司的競爭策略以獨特的科學、可擴展的製造和一體化的服務模式為中心，以確保與競爭對手的差異化和獲利能力。

競爭趨勢日益取決於能否將科學可靠性與可擴展的生產能力和法規遵從性結合。主要企業正投資於菌株表徵、專利酶技術和多位點穩定性測試，以確保其產品功效不受物種或配方限制。除了產品創新之外，成功的企業還透過投資供應鏈來提升自身競爭力，例如在地化生產、契約製造夥伴關係以及生物活性材料的強化低溫運輸物流。這些能力縮短了產品上市時間，並使其在商品化帶來的價格壓力下獲得競爭優勢。

領導者可採取的策略重點是將科學創新轉化為具有韌性的供應鏈、檢驗的配方和在地化最佳化的商業模式。

產業領導者應優先考慮一系列切實可行的舉措，將科學潛力轉化為商業性成功。首先，研發藍圖應與物種特異性證據的創建一致，這些證據應著重於農場層面的最終目標，例如飼料轉換率、發病率降低以及在環境條件波動下的耐受性。其次，投資配方和輸送技術，以保護生物活性成分在加工和儲存過程中不受損害，從而擴大分銷範圍並減少產品損失。第三，透過雙重採購、在地化生產和策略性庫存佈局來增強供應鏈韌性，進而降低關稅和物流中斷帶來的風險。

一種結合一手訪談、文獻整合、農場檢驗和基於情境的供應鏈壓力測試的調查方法，以獲得實用見解。

本調查方法整合了訪談、文獻綜述和跨領域檢驗研討會，以確保研究結果的穩健性、可重複性和對商業性決策的實用性。一手資料包括對飼料生產商、原料供應商和大型生產商的研發經理、採購專家和銷售經理進行的結構化訪談，並輔以農場案例研究，檢驗產品在生產環境中的表現。二手資料則來自同行評審期刊、監管出版刊物和行業會議論文集，使分析與最新的科學共識和政策趨勢保持一致。

摘要將腸道健康定位為系統層面的策略重點，需要證據、韌性和在地化的商業化。

總之，腸道健康正日益成為一個策略性領域，科學、監管、供應鏈和商業性執行在此交匯融合。微生物組研究的進展、監管政策逐漸減少對抗生素的使用，以及更強大的製劑和遞送技術的出現，都為生產商和製劑研發人員提供了更多選擇。同時，2025年的貿易和關稅趨勢凸顯了供應鏈彈性和區域製造能力的重要性。為了在這種環境下取得成功，企業必須整合嚴謹的證據產生、靈活的籌資策略以及針對特定區域的市場進入模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物腸道健康市場：依產品類型分類

  • 酵素
    • 植酸酶
    • 蛋白酶
    • 木聚醣酶
  • 有機酸
  • 植物源
  • 益生元
  • 益生菌
    • 細菌益生菌
    • 酵母來源的益生菌

第9章：動物腸道健康市場：依動物類型分類

  • 水產養殖
    • 魚
    • 蝦
  • 伴侶動物
    • 貓
    • 狗
  • 家禽
    • 肉雞
    • 產蛋母雞
    • 土耳其
  • 反芻動物
    • 牛
    • 牛
    • 綿羊和山羊
  • 豬
    • 用於繁殖
    • 肥育豬
    • 母豬和小豬

第10章：以劑型分類的動物腸道保健市場

  • 液體
  • 顆粒
  • 粉末

第11章 動物腸道健康市場：依應用領域分類

  • 飼料添加劑
  • 營養補充品
  • 治療

第12章：動物腸道健康市場：依分銷管道分類

  • 離線
    • 直銷
    • 銷售代理
  • 線上

第13章：動物腸道健康市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：動物腸道健康市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：動物腸道健康市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物腸道健康市場

第17章：中國動物腸道健康市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AB Vista
  • AdvaCare Pharma
  • Archer Daniels Midland Company
  • BASF SE
  • Bluestar Adisseo Co., Ltd.
  • Cargill, Incorporated
  • Evonik Industries AG
  • International Flavors & Fragrances Inc.
  • Kemin Industries, Inc.
  • Kerry Group plc
  • Koninklijke DSM NV
  • Novonesis A/S
  • Zoetis Inc.
Product Code: MRR-501246438090

The Animal Intestinal Health Market was valued at USD 4.52 billion in 2025 and is projected to grow to USD 4.79 billion in 2026, with a CAGR of 6.17%, reaching USD 6.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.52 billion
Estimated Year [2026] USD 4.79 billion
Forecast Year [2032] USD 6.88 billion
CAGR (%) 6.17%

A strategic introduction that situates intestinal health as a core commercial and sustainability lever across animal production systems guided by microbiome science

The landscape of animal intestinal health has evolved from niche nutritional supplements to a central pillar of livestock, aquaculture, and companion animal production systems. Advances in microbiome science have reframed intestinal health as a multifactorial outcome driven by feed formulation, targeted bioactives, host immunity, and management practices. As a result, producers and value chain stakeholders are increasingly orienting strategy around interventions that optimize gut function to improve resilience, resource efficiency, and animal welfare.

Concurrently, regulatory momentum away from medically important antibiotics and toward evidence-based alternatives has elevated demand for precision feed additives and targeted nutritional strategies. This shift is accompanied by technological integration in product delivery, diagnostic monitoring, and data-driven decision-making. Collectively, these developments mean that intestinal health is no longer an isolated technical consideration but a strategic lever for profitability, sustainability, and market differentiation across species and production systems.

How converging scientific breakthroughs, regulatory pressure, and digital logistics are accelerating integrated product innovation and adoption across animal intestinal health

The past five years have witnessed transformative shifts that are reshaping product portfolios, supply chains, and buyer expectations in the intestinal health arena. Scientific advancements have broadened the palette of efficacious interventions beyond single-mode solutions to integrated regimens that combine enzymes, organic acids, phytogenics, prebiotics, and probiotics with performance diagnostics. This integration has been accelerated by improvements in strain characterization, encapsulation technologies that enhance stability, and granular formulations that match species- and life-stage-specific physiological needs.

In addition, regulatory and market pressures have incentivized the replacement of broad-spectrum antimicrobial growth promotants with evidence-based alternatives, catalyzing investment in clinical trials, biomarker development, and on-farm validation studies. Parallel to product innovation, digital and logistics innovations are enabling more precise dosing, traceability, and rapid-response supply adjustments, thereby reducing the time between scientific discovery and commercial adoption. Taken together, these shifts are creating a more complex but opportunity-rich landscape in which cross-functional collaboration between R&D, regulatory, and commercial teams becomes a competitive necessity.

Assessment of 2025 tariff impacts on ingredient sourcing, formulation decisions, and supply chain resilience within the animal intestinal health ecosystem

The introduction of new tariff measures in 2025 has introduced a tangible layer of trade and cost complexity for stakeholders who depend on cross-border ingredient flows and formulated products. Tariffs affect the economics of imported enzymatic complexes, specialty organic acids, and proprietary probiotic strains, prompting manufacturers and distributors to reassess sourcing strategies and inventory policies. In practice, this means procurement teams are increasingly evaluating supplier diversification, local manufacturing partnerships, and backward integration to maintain supply continuity while managing landed costs.

Moreover, tariff-induced price signals are reinforcing demand for domestically producible inputs and regionally tailored formulations. As a result, some value chain players are accelerating formulation simplification where feasible, while others are investing in ingredient substitution studies and stability testing to validate locally available alternatives. These dynamics have downstream implications for product differentiation, with premium solutions that demonstrate verifiable performance and cost-efficiency gaining competitive advantage. In parallel, the regulatory scrutiny accompanying tariff policy is encouraging transparency in sourcing and compliance, further increasing the administrative burden on smaller suppliers and creating consolidation pressures across the distribution channel.

Segment-focused insights revealing how product type, species physiology, application intent, formulation constraints, and distribution strategy determine development pathways

Insightful segmentation analysis reveals differentiated demand drivers and product development priorities across product type, animal type, application, formulation, and distribution channel segments. Based on Product Type, the market is studied across Enzymes, Organic Acids, Phytogenics, Prebiotics, and Probiotics, with Enzymes further studied across Phytase, Protease, and Xylanase and Probiotics further delineated into Bacterial Probiotics and Yeast Probiotics; this delineation highlights the need for formulation science that aligns catalytic activity, pH tolerance, and microbial compatibility with target feed matrices. Based on Animal Type, the market is studied across Aquaculture, Companion Animals, Poultry, Ruminants, and Swine, with Aquaculture further studied across Fish and Shrimp, Companion Animals across Cat and Dog, Poultry across Broiler, Layer, and Turkey, Ruminants across Beef Cattle, Dairy Cattle, and Sheep And Goat, and Swine across Breeder, Grower Finisher, and Sow And Piglet; these distinctions underscore species- and lifecycle-specific gut physiology that dictates different dosing strategies, carrier systems, and evidence thresholds for efficacy.

Based on Application, the market is studied across Feed Additive, Nutritional Supplement, and Therapeutic, which implies divergent regulatory pathways, claims substantiation demands, and commercial channels for adoption, while Based on Formulation, the market is studied across Liquid, Pellet, and Powder, indicating formulation constraints related to stability, heat tolerance, and on-farm handling. Finally, Based on Distribution Channel, the market is studied across Offline and Online, with Offline further studied across Direct Sales and Distributor, reflecting evolving go-to-market strategies where direct-to-producer models coexist with distributor networks and digital commerce. Collectively, these segmentation lenses reveal that product development, regulatory strategy, and commercial execution must be tightly aligned to species-specific biology, application intent, and preferred delivery format to accelerate adoption and demonstrate measurable outcomes.

Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, regulatory strategy, and commercialization

Regional differentiation is a decisive factor for supply strategies, regulatory compliance, and on-farm adoption, with distinct dynamics in the Americas, Europe, Middle East & Africa, and Asia-Pacific shaping commercial opportunity and risk. In the Americas, demand drivers are shaped by large-scale commercial poultry and swine operations that prioritize feed conversion and antimicrobial stewardship, prompting rapid adoption of enzyme and probiotic-based interventions that integrate with precision feeding platforms. In Europe, Middle East & Africa, regulatory frameworks and consumer expectations emphasize antibiotic reduction and traceability, which fuels demand for rigorously validated, documentation-ready solutions and encourages partnerships between ingredient innovators and local formulators.

In Asia-Pacific, intensive aquaculture and mixed-species production present both scale and complexity, driving demand for tailored enzyme blends, robust acidifiers, and locally relevant probiotic strains, while online distribution and contract manufacturing models enable rapid scaling. Across regions, the interplay between regional raw material availability, divergent regulatory regimes, and distribution infrastructure necessitates adaptive market entry strategies that balance local partnerships, regulatory intelligence, and formulation flexibility. Consequently, companies that develop region-specific evidence packages and operational models are better positioned to capture cross-border growth while mitigating trade and compliance risks.

Competitive company strategies centered on proprietary science, scalable manufacturing, and integrated service models to secure differentiation and margin

Competitive dynamics are increasingly influenced by the ability to combine scientific credibility with scalable manufacturing and regulatory competence. Key companies are investing in strain characterization, patent-protected enzyme technologies, and multi-site stability studies to substantiate product claims across species and formulations. In addition to product innovation, successful firms are differentiating through supply chain investments such as localized production, contract manufacturing partnerships, and enhanced cold-chain logistics for sensitive biologicals. These capabilities reduce time to market and provide a competitive moat against commodity pricing pressures.

Furthermore, strategic partnerships between ingredient innovators, feed formulators, and service providers are becoming more common, enabling bundled offerings that pair actives with dosers, diagnostics, and on-farm training. This ecosystem approach increases switching costs for end users and creates opportunities for value-added services that extend beyond the point of sale. For leadership teams, the takeaway is clear: scaling R&D, ensuring regulatory readiness across target markets, and embedding distribution and technical service within commercial models are essential to sustain growth and defend margin in a rapidly professionalizing market.

Actionable strategic priorities for leaders to convert scientific innovation into resilient supply chains, validated formulations, and regionally tailored commercial models

Industry leaders should prioritize a set of actionable initiatives to convert scientific promise into commercial outcomes. First, align R&D roadmaps with species-specific evidence generation that addresses on-farm endpoints such as feed efficiency, morbidity reduction, and resilience under variable environmental conditions. Second, invest in formulation and delivery technologies that protect biological actives across processing and storage environments, enabling broader distribution and lower product loss. Third, pursue supply chain resilience through dual-sourcing, regional manufacturing, and strategic inventory positioning to mitigate tariff and logistics disruption risks.

In parallel, commercial teams should develop regionally tailored value propositions that reflect local regulatory expectations and buyer purchasing patterns, including digital channels for technical education and sales conversion. Executives should also consider strategic partnerships that combine diagnostic capabilities with product bundles to demonstrate measurable outcomes and create recurring-service revenue. Finally, establish cross-functional commercialization sprints that rapidly translate trial results into label claims, marketing assets, and distributor training, thereby shortening the adoption curve and improving return on innovation investment.

Methodological framework combining primary interviews, literature synthesis, on-farm validation, and scenario-based supply chain stress testing for actionable findings

The research methodology synthesizes primary interviews, secondary literature review, and cross-functional validation workshops to ensure findings are robust, replicable, and relevant to commercial decision-making. Primary inputs include structured interviews with R&D leaders, procurement specialists, and commercial managers across feed manufacturers, ingredient suppliers, and large producers, complemented by on-farm case studies that validate product performance under production conditions. Secondary inputs are drawn from peer-reviewed journals, regulatory publications, and industry conference proceedings to ground analysis in current scientific consensus and policy trends.

Analytical approaches include comparative formulation analysis, supply chain stress testing under alternative tariff and logistics scenarios, and segmentation mapping that links product attributes to species-specific physiological requirements and application intents. Findings were triangulated through expert workshops and sensitivity checks to ensure practical relevance. Wherever possible, methodological transparency was maintained by documenting data sources, interview protocols, and assumptions used in constructing scenario analyses and strategic recommendations.

Concluding synthesis that positions intestinal health as a systems-level strategic priority requiring evidence, resilience, and regionally tailored commercialization

In conclusion, intestinal health is an increasingly strategic domain that intersects science, regulation, supply chain, and commercial execution. The convergence of microbiome research, regulatory shifts away from antibiotics, and the advent of more robust formulation and delivery technologies has expanded the toolkit available to producers and formulators. At the same time, trade dynamics and tariff developments in 2025 have underscored the importance of supply chain agility and regional manufacturing capabilities. To win in this environment, companies must integrate rigorous evidence generation with resilient sourcing strategies and region-specific go-to-market models.

Looking ahead, the organizations that will succeed are those that treat intestinal health as a systems-level challenge rather than a discrete product category. By investing in species-specific efficacy studies, formulation science, and operational resilience, stakeholders can translate technical innovations into commercial advantage while meeting evolving regulatory and consumer expectations. The recommended path forward emphasizes cross-functional collaboration, regional adaptation, and measurable outcome orientation to sustainably capture the value inherent in healthier animals and more efficient production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Intestinal Health Market, by Product Type

  • 8.1. Enzymes
    • 8.1.1. Phytase
    • 8.1.2. Protease
    • 8.1.3. Xylanase
  • 8.2. Organic Acids
  • 8.3. Phytogenics
  • 8.4. Prebiotics
  • 8.5. Probiotics
    • 8.5.1. Bacterial Probiotics
    • 8.5.2. Yeast Probiotics

9. Animal Intestinal Health Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animals
    • 9.2.1. Cat
    • 9.2.2. Dog
  • 9.3. Poultry
    • 9.3.1. Broiler
    • 9.3.2. Layer
    • 9.3.3. Turkey
  • 9.4. Ruminants
    • 9.4.1. Beef Cattle
    • 9.4.2. Dairy Cattle
    • 9.4.3. Sheep And Goat
  • 9.5. Swine
    • 9.5.1. Breeder
    • 9.5.2. Grower Finisher
    • 9.5.3. Sow And Piglet

10. Animal Intestinal Health Market, by Formulation

  • 10.1. Liquid
  • 10.2. Pellet
  • 10.3. Powder

11. Animal Intestinal Health Market, by Application

  • 11.1. Feed Additive
  • 11.2. Nutritional Supplement
  • 11.3. Therapeutic

12. Animal Intestinal Health Market, by Distribution Channel

  • 12.1. Offline
    • 12.1.1. Direct Sales
    • 12.1.2. Distributor
  • 12.2. Online

13. Animal Intestinal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Intestinal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Intestinal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Intestinal Health Market

17. China Animal Intestinal Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AB Vista
  • 18.6. AdvaCare Pharma
  • 18.7. Archer Daniels Midland Company
  • 18.8. BASF SE
  • 18.9. Bluestar Adisseo Co., Ltd.
  • 18.10. Cargill, Incorporated
  • 18.11. Evonik Industries AG
  • 18.12. International Flavors & Fragrances Inc.
  • 18.13. Kemin Industries, Inc.
  • 18.14. Kerry Group plc
  • 18.15. Koninklijke DSM N.V.
  • 18.16. Novonesis A/S
  • 18.17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 306. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 308. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 309. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 313. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 322. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 323. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 324. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (US